2022
Expanding APHON’s Pediatric Chemotherapy/Biotherapy Provider and Instructor Program to Spanish-Speaking Countries: Pilot Series Development and Evaluation
Sullivan C, Weber L, Lamas P, Diaz D, Lu Z, Zhao X, Salinas-Avila S, Ramos R, Belderson K, Challinor J. Expanding APHON’s Pediatric Chemotherapy/Biotherapy Provider and Instructor Program to Spanish-Speaking Countries: Pilot Series Development and Evaluation. Journal Of Pediatric Hematology/Oncology Nursing 2022, 40: 119-132. PMID: 36285475, PMCID: PMC10073235, DOI: 10.1177/27527530221121729.Peer-Reviewed Original ResearchCharacteristics and productivity of the chiropractic workforce of the Veterans Health Administration
Corcoran KL, Peterson DR, Zhao X, Moran EA, Lisi AJ. Characteristics and productivity of the chiropractic workforce of the Veterans Health Administration. Chiropractic & Manual Therapies 2022, 30: 18. PMID: 35410303, PMCID: PMC8996387, DOI: 10.1186/s12998-022-00429-1.Peer-Reviewed Original ResearchConceptsVeterans Health AdministrationTotal work relative value unitsHealth AdministrationChiropractic workforceWork relative value unitsUnited States Veterans Health AdministrationFull-time equivalentsCharacteristics of chiropractorsVHA administrative dataHealthcare systemMultivariable regression modelsClinical full-time equivalentChiropractic careClinical productivityVHA facilitiesVHA's experienceCare deliveryOlder ageChiropractorsRelative value unitsFiscal year 2016Administrative dataAdministrationThe rate of use of Veterans Affairs chiropractic care: a 5-year analysis
Burdick R, Corcoran KL, Zhao X, Lisi A. The rate of use of Veterans Affairs chiropractic care: a 5-year analysis. Chiropractic & Manual Therapies 2022, 30: 4. PMID: 35062971, PMCID: PMC8781440, DOI: 10.1186/s12998-022-00413-9.Peer-Reviewed Original ResearchConceptsChiropractic careCorporate Data WarehouseChiropractic useVA facilitiesVeterans AffairsChiropractic servicesVeteran populationVA Corporate Data WarehouseFacility characteristicsCommunity care useMethodsCross-sectional analysisVA chiropractic servicesNon-pharmacologic treatmentsCommunity care providersCare delivery mechanismsUnique veteransRate of useMusculoskeletal conditionsCare useSite careHigh prevalenceCare providersVeterans' useChiropractic workforceUS populationIdentifying highly heritable brain amyloid phenotypes through mining Alzheimer's imaging and sequencing biobank data.
Bao J, Wen Z, Kim M, Zhao X, Lee BN, Jung SH, Davatzikos C, Saykin AJ, Thompson PM, Kim D, Zhao Y, Shen L, . Identifying highly heritable brain amyloid phenotypes through mining Alzheimer's imaging and sequencing biobank data. Biocomputing 2022, 27: 109-120. PMID: 34890141, PMCID: PMC8730532.Peer-Reviewed Original Research
2021
High-Dose Buprenorphine Induction in the Emergency Department for Treatment of Opioid Use Disorder
Herring AA, Vosooghi AA, Luftig J, Anderson ES, Zhao X, Dziura J, Hawk KF, McCormack RP, Saxon A, D’Onofrio G. High-Dose Buprenorphine Induction in the Emergency Department for Treatment of Opioid Use Disorder. JAMA Network Open 2021, 4: e2117128. PMID: 34264326, PMCID: PMC8283555, DOI: 10.1001/jamanetworkopen.2021.17128.Peer-Reviewed Original ResearchConceptsOpioid use disorderEmergency departmentBuprenorphine inductionRespiratory depressionAdverse eventsUse disordersUntreated opioid use disorderSerious adverse eventsFurther prospective investigationLength of stayUrban emergency departmentSafety-net hospitalAdvanced practice practitionersElectronic health recordsUnique cliniciansSublingual buprenorphineBuprenorphine doseED visitsED encountersCase seriesED patientsED physiciansSupplemental oxygenMedian lengthUnique patientsCognitive performance as a predictor of healthcare transition in sickle cell disease
Saulsberry‐Abate A, Partanen M, Porter J, Podila P, Hodges J, King A, Wang W, Schreiber J, Zhao X, Kang G, Jacola L, Hankins J. Cognitive performance as a predictor of healthcare transition in sickle cell disease. British Journal Of Haematology 2021, 192: 1082-1091. PMID: 33570182, PMCID: PMC8092972, DOI: 10.1111/bjh.17351.Peer-Reviewed Original Research
2020
The effects of repetitive transcranial magnetic stimulation on cue-induced craving in male patients with heroin use disorder
Liu X, Zhao X, Liu T, Liu Q, Tang L, Zhang H, Luo W, Daskalakis ZJ, Yuan TF. The effects of repetitive transcranial magnetic stimulation on cue-induced craving in male patients with heroin use disorder. EBioMedicine 2020, 56: 102809. PMID: 32512513, PMCID: PMC7276507, DOI: 10.1016/j.ebiom.2020.102809.Peer-Reviewed Original ResearchConceptsOpioid use disorderRepetitive transcranial magnetic stimulationDorsolateral prefrontal cortexTranscranial magnetic stimulationTreatment cessationHz rTMSMagnetic stimulationUse disordersHeroin use disorder patientsDaily consecutive sessionsHeroin use disorderLeft dorsolateral prefrontal cortexTreatment effectsWait-list groupCue-induced cravingHeroin patientsMale patientsDisorder patientsHeroin usersPatientsList groupRehabilitation centerSuch treatment effectsPrefrontal cortexRTMS
2019
Impact of MYCN status on response of high-risk neuroblastoma to neoadjuvant chemotherapy
Yanishevski D, McCarville M, Doubrovin M, Spiegl H, Zhao X, Lu Z, Federico S, Furman W, Murphy A, Davidoff A. Impact of MYCN status on response of high-risk neuroblastoma to neoadjuvant chemotherapy. Journal Of Pediatric Surgery 2019, 55: 130-134. PMID: 31685267, DOI: 10.1016/j.jpedsurg.2019.09.067.Peer-Reviewed Original ResearchConceptsNon-amplified tumorsNeoadjuvant chemotherapyHigh-risk neuroblastomaCurie scoreTumor responseMYCN amplificationGreater mean percentage reductionHigh-risk neuroblastoma patientsMetastatic disease responsePrimary tumor responsePercentage of patientsPrimary tumor volumeAggressive clinical phenotypeMean percentage reductionPercentage volume changeLocoregional diseaseSurgical resectionMetastatic sitesNeuroblastoma patientsPrimary tumorTumor resectionTumor volumeCT scanMYCN statusChemotherapy
2012
Involvement of Autophagy in Cardiac Remodeling in Transgenic Mice with Cardiac Specific Over-Expression of Human Programmed Cell Death 5
An L, Zhao X, Wu J, Jia J, Zou Y, Guo X, He L, Zhu H. Involvement of Autophagy in Cardiac Remodeling in Transgenic Mice with Cardiac Specific Over-Expression of Human Programmed Cell Death 5. PLOS ONE 2012, 7: e30097. PMID: 22253891, PMCID: PMC3256219, DOI: 10.1371/journal.pone.0030097.Peer-Reviewed Original ResearchConceptsCardiac remodelingTransgenic miceAlpha-myosin heavy chain promoterCell death 5Angiotensin II treatmentTransverse aortic constrictionMyosin heavy chain promoterRole of PDCD5Death 5Reduced survival rateFetal gene programHeavy chain promoterHeart failureControl miceAngiotensin IIHeart weightHistopathological examinationAortic constrictionReal-time RT-PCR analysisInvolvement of autophagyII treatmentCardiac hypertrophyImmunohistochemistry analysisBody weightSurvival rate